4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-064681
Director acquired 12,485 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2026-02-20 | Option exercise | +12,485 | $4.95 | $61,801 | 65,890 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2026-02-20 | Option exercise · Stock Option (Right to Buy) | −12,485 | 13,971 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…